General principle of immunoassay Theoretical basis and optimization of immun...Ashish Gadage
Unlock the mysteries of immunoassays with this comprehensive PowerPoint presentation. Delve into the fundamental principles that underpin immunoassay techniques, exploring the theoretical foundations and key concepts. From antigen-antibody interactions to signal amplification strategies, this presentation provides valuable insights into the world of immunoassay science.
Key Topics:
Basics of Immunoassay: Antigen-Antibody Interactions
Types of Immunoassays: ELISA, Western Blot, and More
Signal Detection and Amplification Techniques
Factors Affecting Assay Sensitivity and Specificity
Optimization Strategies for Enhanced Performance
Emerging Trends in Immunoassay Technology
Who Should View:
Designed for scientists, researchers, and students in the fields of immunology, biochemistry, and medical diagnostics. Whether you're new to immunoassays or seeking advanced insights, this presentation caters to a broad audience.
Presenter: Mr. Gadage Ashish Rambhau
(M Pharm Pharmacology)
Pravara Rural Education Society pravaranagar,Loni .
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
Hybridoma technology revolutionized the field of immunology by enabling the production of monoclonal antibodies with high specificity and affinity. This presentation delves into the principles of DNA hybridoma technology, highlighting its significance in antibody production, therapeutic applications, and biomedical research. Learn about the key steps involved in generating hybridomas, from immunization to antibody screening, and discover the potential of recombinant DNA techniques in enhancing antibody engineering. Whether you're a student, researcher, or industry professional, this overview will provide valuable insights into the innovative world of hybridoma technology."
Uncover the wide-ranging applications of monoclonal antibodies in areas such as cancer therapy, autoimmune diseases, infectious diseases, and beyond. Learn about the latest advancements in antibody engineering and the development of novel therapeutic modalities, including bispecific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors.
Whether you're a seasoned researcher or a newcomer to the field, this SlideShare presentation serves as a valuable resource for understanding the principles, techniques, and applications of hybridoma technology in modern biomedicine. Join a journey through the fascinating world of monoclonal antibodies and the groundbreaking science behind their creation.
Unlock the potential of hybridoma technology and propel your research to new heights. Dive into this SlideShare presentation now and explore the limitless possibilities of monoclonal antibody production with hybridoma technology.
General principle of immunoassay Theoretical basis and optimization of immun...Ashish Gadage
Unlock the mysteries of immunoassays with this comprehensive PowerPoint presentation. Delve into the fundamental principles that underpin immunoassay techniques, exploring the theoretical foundations and key concepts. From antigen-antibody interactions to signal amplification strategies, this presentation provides valuable insights into the world of immunoassay science.
Key Topics:
Basics of Immunoassay: Antigen-Antibody Interactions
Types of Immunoassays: ELISA, Western Blot, and More
Signal Detection and Amplification Techniques
Factors Affecting Assay Sensitivity and Specificity
Optimization Strategies for Enhanced Performance
Emerging Trends in Immunoassay Technology
Who Should View:
Designed for scientists, researchers, and students in the fields of immunology, biochemistry, and medical diagnostics. Whether you're new to immunoassays or seeking advanced insights, this presentation caters to a broad audience.
Presenter: Mr. Gadage Ashish Rambhau
(M Pharm Pharmacology)
Pravara Rural Education Society pravaranagar,Loni .
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
Hybridoma technology revolutionized the field of immunology by enabling the production of monoclonal antibodies with high specificity and affinity. This presentation delves into the principles of DNA hybridoma technology, highlighting its significance in antibody production, therapeutic applications, and biomedical research. Learn about the key steps involved in generating hybridomas, from immunization to antibody screening, and discover the potential of recombinant DNA techniques in enhancing antibody engineering. Whether you're a student, researcher, or industry professional, this overview will provide valuable insights into the innovative world of hybridoma technology."
Uncover the wide-ranging applications of monoclonal antibodies in areas such as cancer therapy, autoimmune diseases, infectious diseases, and beyond. Learn about the latest advancements in antibody engineering and the development of novel therapeutic modalities, including bispecific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors.
Whether you're a seasoned researcher or a newcomer to the field, this SlideShare presentation serves as a valuable resource for understanding the principles, techniques, and applications of hybridoma technology in modern biomedicine. Join a journey through the fascinating world of monoclonal antibodies and the groundbreaking science behind their creation.
Unlock the potential of hybridoma technology and propel your research to new heights. Dive into this SlideShare presentation now and explore the limitless possibilities of monoclonal antibody production with hybridoma technology.
Immunohistochemistry (IHC) is the localization of a known antigen in tissues by utilizing antibodies directed towards that (specific) antigen. In this presentation, we will introduce the procedure of IHC and the troubleshooting solutions.
ELISA or Enzyme-linked Immunosorbent Assay is a qualitative and quantitative assay for detecting the presence of antigens (virus, hormones, enzymes, etc.) in a sample.
The following presentation contains helpful information regarding Radioimmunoassay (RIA) and Enzyme-Linked Immunosorbent Assay (ELISA), including their history, introduction, advantages, procedures and applications.
Pharmaceutical biotechnology ..in that different blotting techniques such as ELISA , western blotting and southern blotting.There applications and their advantage and disadvantage with their diagrams
Since antigen and antibody reactions are specific, they can be used to identify each other.
These diagnostic tests are particularly useful in diagnosing for examples: infectious diseases, autoimmune diseases, and in typing of blood and tissues prior to transplantation.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
More Related Content
Similar to BASIC OF IHC BY GEORGE YEABYO-ETHIOPIA.pptx
Immunohistochemistry (IHC) is the localization of a known antigen in tissues by utilizing antibodies directed towards that (specific) antigen. In this presentation, we will introduce the procedure of IHC and the troubleshooting solutions.
ELISA or Enzyme-linked Immunosorbent Assay is a qualitative and quantitative assay for detecting the presence of antigens (virus, hormones, enzymes, etc.) in a sample.
The following presentation contains helpful information regarding Radioimmunoassay (RIA) and Enzyme-Linked Immunosorbent Assay (ELISA), including their history, introduction, advantages, procedures and applications.
Pharmaceutical biotechnology ..in that different blotting techniques such as ELISA , western blotting and southern blotting.There applications and their advantage and disadvantage with their diagrams
Since antigen and antibody reactions are specific, they can be used to identify each other.
These diagnostic tests are particularly useful in diagnosing for examples: infectious diseases, autoimmune diseases, and in typing of blood and tissues prior to transplantation.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. PRESENTER
Giorgis Yeabyo
- Representative of America Society for Clinical pathologists (ASCP) in Africa
- Representative of National Society of Histotechnologists, USA and blogger
- Certified Professional healthcare Quality (CPHQ)
- LQMS expert
- Representative of Joint Commission International in East Africa
- Consultant of Ethiopian Accreditation Service (EAS)
3. OUTLINE
• INTRODUCTION
• TARGET ANTIGEN
• PRIMARY ATIBODY
• SECONDARY ANTIBODY
• THE CHROMOGEN
• MAKE SURE BEFORE STAINING OF IHC
• STEPS FOR IHC STAINING
• TROUBLSHOOTINGS
4. INTRODUCTION
• IHC is used in histology to detect the presence of a specific
protein marker that can assist with accurate tumor
classification and diagnosis.
• Used for almost half a century
• is a complement for H&E and special stain to fulfill the
diagnostic capability.
5. TARGET ANTIGEN
• Antigens are proteins that are within or on the surface of a cell.
• Pathologists look for the presence or absence of particular
antigens to assist with diagnosis.
• There are many hundreds of antigens that have been found to be
diagnostically useful.
• Pathologists use a “panel” of multiple antigens to help fully
classify a particular tumor.
6. PRIMARY Ab & SECONDARY Ab
• The first stage of IHC is the application of a primary antibody that binds
specifically to the target antigen.
• There are two types of antibodies 1) Monoclonal 2) Polyclonal antibody
• Polyclonal antibodies have an affinity with, and bind to, multiple epitopes
(or parts) or the target antigen, and as such are more prone to cross-react
to non-target antigens.
• Monoclonal antibodies have an affinity to only one epitope and tend to
produce cleaner, more specific staining but are less sensitive or intense.
8. Monoclonal Vs Polyclonal Ab
Monoclonal
• Produced by same clone of
plasma B cell
• Homogenous Ab population
• Interact with particular
epitope on Ag
Polyclonal
• Produced by multiple clones
of plasma B cell
• Heterogenous Ab population
• Interact with different epitope
on the same Ag
9.
10. PRIMARY Ab
• There are two types of detection system:
1- Ag-Ab-Chromogen (Direct) and
2-Ag- Ab-Ab-Chromogen (Indirect)
• The most sensitive and specific is the Indirect method of
detection
12. THE CHROMOGEN
• If the tumor is positive, a substrate forms an insoluble colored precipitate
that can be visualized under a microscope.
• There are two commonly used chromogens: DAB (brown) or AP (red).
• DAB is used for most applications as it provides strong and permanent stains.
• AP Red (or another red chromogen) is used mainly for skin sections where
the brown DAB may be masked by brown melanin pigment.
• Both DAB and AP Red are sometimes used in the same tissue section to allow
the pathologist to visualize two antigens in the one slide. This is a process
known as double staining.
13. MAKE SURE BEFORE STAINING OF IHC
• Ensure Optimal Fixation :- Fixation plays an important role in IHC staining
and the Cold ischemic time should be respected.
• https://www.youtube.com/watch?v=4VMOWRTD-h8
• Use High quality Sections:- Use a charged slide (**) and try your best to have
a very good section by a microtome.
14. Avoid the use of protein-based section adhesives in the flotation
bath (glue, starch, or gelatin), particularly on charged slides.
15. Sections A and B are micrographs taken from opposite ends of the same slide. One end of the slide
shows strong staining (A) whereas at the other end (B) the staining was very weak. This is an extreme
example of a concentration gradient created during staining (tonsil, CD45).
Avoid Concentration Gradients
16. Choose Antibody Carefully
• Choose your primary antibody carefully with regard to its sensitivity
and specificity.
• Be aware that antibodies sold by different suppliers often come from
the same source and are repackaged/branded for sale.
• It is important to use the clone name when assessing an antibody.
“We buy our antibodies based on price alone.”
17. Choose Ab Carefully
• A simple, but sometimes overlooked step is to choose antibodies that work for
immunohistochemistry.
• This can save you a lot of headaches down the road. Search for specific antibodies
from literature, vendors, as well as your peers.
• There are several things to keep in mind with antibodies. What might work well in
one laboratory might not be optimal for your laboratory. Each antibody needs to be
tested with your staining system. Antibodies over time can lose their staining
intensity. Exposure to air and light can cause this.
18. Concentrates Vs Ready-To-Use (RTU) antibodies
• Concentrates are flexible, have a lower initial purchase price, and can generally be
used within any staining system, both automated and manual, subject to the
manufacturer’s recommendations.
• The working dilution of concentrates can be optimized to balance cost, staining time,
and quality.
• concentrates do require preparation time and validation. As there is no definitive way
of determining the properties and stability of a diluted antibody without well
controlled and executed studies, staining quality may be compromised
• The advantages of RTUs include increased laboratory efficiency, better quality
control, and easier reagent management.
19. These sections of human tonsil from the same block have been stained with the B cell
marker CD20 using primary monoclonal antibodies from different sources (suppliers).
In each case, the recommended pretreatment and optimized dilution were used.
There is an obvious difference in the quality of the results achieved.
20. Read Specification Sheets
Know your primary antibody. Always check the specification sheet to determine the
suitability of your method for a particular antibody. Specification sheets should be
updated when a new batch of antibody is purchased.
21. Optimize Retrieval Methods
Choose appropriate unmasking conditions for the primary antibody being
used, the tissue being stained, and the fixation employed (pH, reagent,
reaction conditions).
The same retrieval technique is used for all primaries on the assumption
that there is a successful universal HIER method.
22. Prostate sections stained for Cytokeratin 34βE12. Section A shows weak staining
while section B is stronger and sharper. The only difference between the two was
the retrieval method used.
23. Block Endogenous Peroxidase
• For peroxidase-based detection systems, always use a peroxidase-
blocking step.
• Non-specific staining is often seen in erythrocytes, granulocytes,
monocytes, and in muscle. This is due to incompletely-blocked
endogenous peroxidase.
24. Spleen showing typical, non-specific staining of erythrocytes due to incomplete
blocking of endogenous peroxidase. Here the natural peroxidase present in the red
cells has reacted with the DAB chromogen.
25. Standardize Washing Steps
• Use standardized washing steps throughout (duration, volume, and form of
agitation). This will ensure the consistency of results.
• Results are very variable within runs with the same antibody and between
runs on different days. This can be due to different washing techniques used by
different operators.
26. Sections A and B are from the same specimen and have been stained manually using the same
reagents. Note the difference in the level of background staining in the stratified epithelium.
This is probably due to a difference in the efficiency of the washing technique used (tonsil,
CD20).
27. Optimize Counterstaining
• The level of nuclear counterstain is carefully regulated and standardized so as
not to obscure positive staining.
• The counterstain should provide the best possible contrast between chromogen
and background tissue elements.
• An appropriate counterstain is chosen for the chromogen used.
• Nuclear counterstain is sometimes very strong. This can obscure weak specific
staining.
28. Tonsil stained for Ki67, a nuclear marker for proliferating cells. The two sections are from the
same specimen showing different levels of hematoxylin counterstaining. Slide A shows staining
that is too strong and would obscure a weak positive reaction. Slide B shows a better level of
staining.
29. Use Appropriate Controls
• Always use appropriate positive and negative controls that are
carefully examined to validate results.
• Internal positive and negative controls are also important and
provide an excellent means of ensuring quality assurance in IHC .
• It is not a wastage of Abs or reagents
30. Evaluate Results Carefully
• Know what to look for and where to look when evaluating your
test sections and controls after staining.
• If staining is observed in test sections, it is assumed the stains are
satisfactory.